ALAB · Astera Labs

32 filings

ALAB SEC Filings

Astera Labs - 32 total filings

Filing record · 2024–202610-K210-Q88-K22

Showing 1–32 of 32 filings

Astera Labs 8-K Report, Financial Results (Nov 3, 2026)

Astera Labs (ALAB) reported robust financial results for the third quarter of 2026, demonstrating significant growth and expanding its product portfolio. The company achieved record quarterly revenue of $584.9 million, representing a substantial 49% increase quarter-over-quarter and a 154% surge year-over-year. This strong performance was driven by the Scorpio™ fabric switches, which have now become the company's largest product family due to the volume production of the Scorpio X-Series 320-lane fabric switch. Beyond revenue, Astera Labs has strategically broadened its offerings with new solutions for memory expansion (Leo 2 and Leo X-Series), optical and copper signal conditioning (Aries 7), and rack-scale AI platforms (Orion). These expansions, coupled with strong design activity and new customer wins, position the company favorably to increase its dollar content per AI accelerator and capture a larger share of the growing AI infrastructure market. The company also provided a confident outlook for the fourth quarter of 2026, projecting revenue between $730 million and $750 million.

Nov 3, 2026 10-Q

Astera Labs Quarterly Report for Q2 Ended Jun 30, 2026

Astera Labs, Inc. (ALAB) reported robust financial performance for the six months ended June 30, 2026, demonstrating significant revenue growth of 99% year-over-year, reaching $700.8 million. This growth was driven by increased unit shipments and higher average selling prices across their product lines, particularly Aries, Scorpio, and Taurus. The company also achieved substantial net income growth of 181% year-over-year, totaling $233.4 million, reflecting strong operational execution and expanding market demand for their Intelligent Connectivity Platform, which serves hyperscalers and AI infrastructure needs. Despite the impressive revenue and profit expansion, gross margin saw a slight decrease of 80 basis points to 74.6% for the six-month period. This was attributed to a shift in product mix towards lower-margin hardware modules and the impact of common stock warrants. Operating expenses, particularly in Research & Development, increased significantly due to headcount expansion and investments in product development, which is crucial for maintaining their market leadership in the rapidly evolving AI infrastructure landscape. The company ended the period with a strong liquidity position, holding over $1.3 billion in cash, cash equivalents, and marketable securities, indicating sufficient resources to fund operations and future growth initiatives.

Aug 5, 2026 8-K

Astera Labs 8-K Report, Financial Results (Aug 4, 2026)

Astera Labs reported second-quarter 2026 revenue of $392.4 million, up 27% sequentially and 104% year-over-year, with GAAP operating income of $89.2 million (22.7% margin) and non-GAAP operating income of $153.5 million (39.1% margin). Growth was broad-based across the Aries, Taurus, Scorpio, and Leo product lines, and the company said Scorpio fabric switches are expected to become its largest product family one quarter earlier than previously expected. GAAP diluted EPS was $0.83 and non-GAAP diluted EPS was $0.80. Note that GAAP net income of $153.1 million was lifted by a $50.3 million income tax benefit, so the non-GAAP tax rate of about 12% is the better guide to recurring earnings power. For the third quarter, management guided revenue to $540-560 million, implying roughly 38-43% sequential growth at the midpoint-to-high end. The outlook calls for GAAP gross margin of about 72%, non-GAAP diluted EPS of $1.16-1.21, and a roughly 185 million weighted-average diluted share count. The guided gross margin is meaningfully below Q2's 73.3% GAAP and 73.7% non-GAAP levels, and the outlook assumes a much higher operating expense base, with non-GAAP opex of $156-160 million versus $115 million implied in Q2. Investors will want to watch whether the Scorpio X-Series ramp sustains this trajectory and whether margins hold as the mix shifts. The balance sheet remains strong, with cash, cash equivalents, and marketable securities of about $1.25 billion at June 30, 2026. However, working capital build is notable: accounts receivable rose to $192.5 million from $83.2 million at year-end, and inventory rose to $113.8 million from $59.0 million, reflecting the revenue ramp. Operating cash flow for the first half was $162.3 million, and the company spent $69.2 million on business combinations during the period, which increased goodwill to $91.6 million. The release is preliminary and the 8-K furnishes the release under Item 2.02 rather than filing it for Section 18 purposes.

Aug 4, 2026 8-K

Astera Labs 8-K Report, Shareholder Vote Results (Jun 8, 2026)

Astera Labs, Inc. (ALAB) filed an 8-K on June 8, 2026, detailing the results of its 2026 Annual Stockholders Meeting held on June 4, 2026. The meeting saw strong participation, with approximately 82.6% of the total outstanding shares being voted. Key outcomes include the re-election of all three Class II director nominees, overwhelmingly ratifying the appointment of PricewaterhouseCoopers LLP as the independent auditor, and approving executive compensation on an advisory basis (Say-on-Pay).

Jun 8, 2026 10-Q

Astera Labs Quarterly Report for Q1 Ended Mar 31, 2026

Astera Labs, Inc. reported robust financial performance for the first quarter of 2026, with significant year-over-year growth in revenue and profitability. Revenue more than doubled, reaching $308.4 million, a 93% increase compared to the same period in 2025, driven by strong demand for their Scorpio, Aries, and Taurus products and higher average selling prices. This revenue surge was accompanied by an expansion in gross margin to 76.3%, up from 74.9% in the prior year, attributed to a favorable product mix. Profitability saw substantial improvement, with operating income soaring by 448% to $61.8 million and net income increasing by 152% to $80.3 million. This strong operational performance was underpinned by strategic investments in research and development, which grew by 95% year-over-year, reflecting the company's commitment to innovation in its Intelligent Connectivity Platform. The company ended the quarter with a healthy liquidity position, holding $1.2 billion in cash, cash equivalents, and marketable securities, and generated a strong $74.6 million in cash flow from operations.

May 6, 2026 8-K

Astera Labs 8-K Report, Financial Results (May 5, 2026)

Astera Labs reported record first-quarter 2026 revenue of $308.4 million, up 14% sequentially and 93% year-over-year, driven by demand for its PCIe 6 switch and signal-conditioning portfolio. GAAP gross margin was 76.3% and GAAP operating income was $61.8 million (20.1% margin). Non-GAAP operating income was $111.7 million (36.2% margin), and non-GAAP diluted EPS was $0.61 versus GAAP diluted EPS of $0.44. GAAP net income of $80.3 million was helped by a $6.9 million income tax benefit, a discrete item, so the operating result is the cleaner measure of earnings power. Investors should note that the release uses non-GAAP figures that exclude stock-based compensation, which was $48.9 million in the quarter, about 16% of revenue. Management guided second-quarter 2026 revenue to $355 million to $365 million, implying roughly 15% to 18% sequential growth, with GAAP and non-GAAP gross margins of about 73%. Non-GAAP diluted EPS is guided to $0.68 to $0.70 on about 184 million shares. The guided gross margin step-down from 76% to 73% and the rise in operating expenses (non-GAAP operating expenses of $128 million to $131 million, up from about $112 million of non-GAAP operating expenses in Q1) indicate investment spending ahead of new product ramps. Management highlighted the Scorpio X-Series 320-lane AI fabric switch, which is shipping now, with production ramp expected in the second half of 2026. The balance sheet remains strong, with about $1.18 billion in cash and marketable securities and $74.6 million of operating cash flow in the quarter. Two items warrant monitoring: accounts receivable rose about 62% sequentially to $134.8 million, well ahead of revenue growth, and goodwill increased to $87.7 million following acquisitions that used $65.0 million of cash. The filing also states that Astera Labs' results are subject to customer concentration, cyclical semiconductor demand, and tariff and geopolitical risks.

May 5, 2026 10-K

Astera Labs Annual Report, Year Ended Dec 31, 2025

Astera Labs, Inc. (ALAB) demonstrated significant financial performance for the year ending December 31, 2025, with revenue soaring to $852.5 million, a substantial 115% increase from the prior year. This robust growth was driven by strong demand across its product lines, particularly Aries, Scorpio, and Taurus, alongside improved average selling prices. The company achieved a net income of $219.1 million, a dramatic turnaround from the net loss of $83.4 million in 2024, signaling strong operational improvements and market traction. Despite a slight decrease in gross margin to 75.7% due to a shift in product mix towards hardware modules, the company effectively managed operating expenses, which decreased by 7% year-over-year primarily due to a significant reduction in non-cash stock-based compensation. Astera Labs continues to invest heavily in research and development, with expenses increasing by 51% to support innovation in its Intelligent Connectivity Platform for cloud and AI infrastructure. The company's strong cash position and positive operating cash flow provide a solid foundation for continued growth and investment in its core technologies.

Feb 20, 2026 8-K

Astera Labs 8-K Report, Material Agreement (Feb 10, 2026)

Astera Labs, Inc. (ALAB) announced on February 10, 2026, that it entered into a Transaction Agreement and a Warrant Agreement with Amazon.com, Inc. (Parent) and Amazon.com NV Investment Holdings LLC (Warrantholder), respectively, on February 5, 2026. This agreement allows for the issuance of a warrant to acquire up to approximately 3.26 million shares of common stock at an exercise price of $142.82 per share. The warrant is tied to performance conditions, specifically requiring Parent and its affiliates to purchase up to $6.5 billion of Astera Labs' smart fabric switch products, signal conditioning products, and optical engine products.

Feb 10, 2026 8-K

Astera Labs 8-K Report, Executive Changes (Feb 10, 2026)

Astera Labs, Inc. (ALAB) has filed an 8-K report detailing a CFO transition. Effective March 2, 2026, Michael Tate will retire as Chief Financial Officer, moving into a Strategic Advisor role to the CEO until September 1, 2026. This transition appears smooth, with no stated disagreements and Tate remaining employed in an advisory capacity. Replacing Mr. Tate will be Desmond Lynch, who brings extensive financial leadership experience from companies like Rambus Inc. and Knowles Corporation. Mr. Lynch's appointment comes with a competitive compensation package, including a base salary of $500,000, a performance bonus target, and significant equity awards in the form of RSUs and PSUs, totaling $9 million in potential long-term incentives. This move signifies a deliberate effort to secure experienced financial leadership as the company progresses.

Feb 10, 2026 8-K

Astera Labs 8-K Report, Financial Results (Feb 10, 2026)

Astera Labs reported preliminary fourth-quarter and full-year 2025 results that showed strong top-line growth and high profitability. Q4 revenue reached a record $270.6 million, up 17% sequentially and 92% year-over-year, with GAAP gross margin of 75.6% and non-GAAP operating margin of 40.2%. Full-year revenue was a record $852.5 million, up 115% from $396.3 million in 2024. GAAP net income for the year was $219.1 million (diluted EPS of $1.22), and non-GAAP pro forma diluted EPS was $1.84. Cash, cash equivalents, and marketable securities totaled roughly $1.19 billion at year-end, up from about $914 million a year earlier. The company's outlook for Q1 2026 calls for revenue of $286 million to $297 million, GAAP gross margin of about 74%, and non-GAAP diluted EPS of $0.53 to $0.54. Management is accelerating R&D investment, opening a design center in Israel, and ramping production of the Scorpio X-Series smart fabric switch for a lead platform. It cites an estimated $20 billion merchant scale-up switching market by 2030. Investors should note that Q4 GAAP tax expense was $33.9 million, compared with a benefit in Q3, which pulled Q4 GAAP net income well below non-GAAP net income. Q1 guidance assumes a GAAP tax rate of about 1%. The results are described as preliminary, and the full Form 10-K has not yet been filed, so figures may change. Risks cited include customer concentration, cyclicality, geopolitical exposure, and the lack of long-term customer commitments.

Feb 10, 2026 8-K

Astera Labs 8-K Report, Executive Changes (Jan 20, 2026)

Astera Labs, Inc. has announced a key leadership change with the appointment of Germaine Cota as its new Chief Accounting Officer and Vice President of Finance, effective January 20, 2026. Ms. Cota brings extensive experience from her previous roles, including Senior Vice President of Finance & Accounting at BILL Holdings, Inc., and Chief Accounting Officer at 8x8, Inc., along with significant tenure at LinkedIn and Ernst & Young. This appointment is crucial for financial reporting and oversight as the company continues its growth trajectory. Investors should note the compensation package offered to Ms. Cota, which includes a base salary of $375,000, a performance bonus target of 50% of her base salary, a $130,000 hiring bonus (subject to clawback), and significant equity awards totaling $4,000,000 in restricted stock units. The equity awards are structured with a combination of immediate and phased vesting over several years, aligning Ms. Cota's incentives with the company's long-term performance and shareholder value.

Jan 20, 2026 10-Q

Astera Labs Quarterly Report for Q3 Ended Sep 30, 2025

Astera Labs, Inc. (ALAB) reported a strong third quarter of 2025, demonstrating significant year-over-year growth. Total revenue surged by 104% to $230.6 million for the three months ended September 30, 2025, and by 128% to $581.9 million for the first nine months of the year, primarily driven by increased unit shipments and a favorable product mix. The company achieved profitability in the current quarter and year-to-date, a significant turnaround from the previous year. This operational improvement is underpinned by robust demand for its Intelligent Connectivity Platform, serving hyperscalers and AI infrastructure needs. Despite increased operating expenses related to headcount growth and R&D initiatives, the company's strategic investments appear to be paying off, with a healthy increase in operating income and a positive net income of $91.1 million for the quarter.

Nov 5, 2025 8-K

Astera Labs 8-K Report, Financial Results (Nov 4, 2025)

Astera Labs (ALAB) reported preliminary third-quarter fiscal 2025 results (quarter ended September 30, 2025) that showed strong growth. Revenue reached a record $230.6 million, up 20% sequentially and 104% year-over-year, driven by new AI platform ramps across multiple product families. GAAP gross margin was 76.2%, GAAP operating income was $55.4 million (24.0% margin), and GAAP diluted EPS was $0.50. Non-GAAP operating income was $96.1 million (41.7% margin) and non-GAAP diluted EPS was $0.49. GAAP net income of $91.1 million was boosted by a $24.3 million income tax benefit, so it overstates operating profitability relative to the operating line. Stock-based compensation of $40.7 million in the quarter accounts for most of the gap between GAAP and non-GAAP operating income. For Q4 2025, management guided revenue to $245 million to $253 million, GAAP gross margin of about 75%, and GAAP diluted EPS of about $0.20, with non-GAAP EPS of about $0.51 on roughly 183 million diluted shares. The GAAP tax rate is guided to about 45% versus a roughly 15% non-GAAP rate, a large spread investors should model carefully. Operating expenses are guided to rise sharply, with GAAP opex of $129 to $134 million versus $120.4 million in Q3. The company also signed a definitive agreement to acquire aiXscale Photonics GmbH, a fiber-chip coupling provider, to expand into photonic scale-up connectivity beyond copper. Balance sheet strength is notable, with cash and marketable securities of roughly $1.13 billion and total stockholders' equity of $1.27 billion as of September 30, 2025. The filing is a furnished Form 8-K under Item 2.02, so the earnings release is not treated as filed for Section 18 liability purposes. The release contains extensive forward-looking statements and risk factors, including customer concentration, cyclicality, tariffs and geopolitical exposure, and the execution risk of the aiXscale acquisition. Investors should weigh the strong growth and margins against customer concentration, the step-up in expenses, and the reliance on a small number of AI platform ramps.

Nov 4, 2025 8-K

Astera Labs 8-K Report, Corporate Update (Oct 22, 2025)

On October 22, 2025, Astera Labs (Nasdaq: ALAB) filed an 8-K under Item 8.01 (Other Events) disclosing that it has entered into a definitive agreement to acquire aiXscale Photonics GmbH, a German photonics company. The press release, furnished as Exhibit 99.1, states the transaction is subject to customary closing conditions. The filing is an announcement of a signed agreement rather than a completed deal, so closing timing and any consideration terms are not disclosed in this document. Strategically, the acquisition is aimed at building Astera Labs' photonic scale-up capability. aiXscale's fiber-chip coupling technology, which the company describes as optical I/O precision glass coupling, would be combined with Astera's connectivity and signal processing portfolio, including its fabric switch and signal conditioning products. Management frames the deal as bringing both talent and photonic technology to support AI Infrastructure 2.0, where optical connectivity is needed for scale-up systems linking hundreds of AI accelerators. For investors, the key takeaways are the strategic direction toward photonics and the acquisition of technology and engineering talent. The filing does not disclose purchase price, financing, expected revenue or margin impact, or the effect on earnings, and the forward-looking statements flag risks including closing failure, integration disruption, customer and employee attrition, unproven photonic chiplet development, and regulatory review. Investors should look to subsequent filings for deal economics and closing status.

Oct 22, 2025 10-Q

Astera Labs Quarterly Report for Q2 Ended Jun 30, 2025

Astera Labs, Inc. reported strong revenue growth in its fiscal second quarter of 2025, with a significant 150% increase year-over-year, driven by higher unit shipments and average selling prices across its Aries, Scorpio, and Taurus product lines. Despite this impressive top-line performance, the gross margin saw a slight decrease due to a shift in product mix towards hardware modules. The company also experienced a substantial increase in operating expenses, primarily due to growth in headcount and R&D initiatives aimed at supporting business expansion and product development. Financially, Astera Labs moved from a net loss in the prior year's comparable period to a substantial net income of $51.2 million for the quarter. This turnaround is further highlighted by the positive net cash provided by operating activities, a significant improvement from the previous year. The company maintains a strong liquidity position with over $1 billion in cash, cash equivalents, and marketable securities, which management believes is sufficient for at least the next 12 months. However, the report also notes material weaknesses in internal control over financial reporting, which the company is actively working to remediate.

Aug 6, 2025 8-K

Astera Labs 8-K Report, Financial Results (Aug 5, 2025)

Astera Labs (ALAB) reported second-quarter 2025 revenue of $191.9 million, up 20% sequentially and 150% year-over-year, with GAAP gross margin of 75.8% and GAAP operating income of $39.8 million (20.7% margin). GAAP diluted EPS was $0.29, and non-GAAP diluted EPS was $0.44 after excluding $35.5 million of stock-based compensation. The company cited a ramp of its PCIe 6 portfolio into volume production for customized rack-scale AI systems, new Scorpio fabric switch design wins, and expanded ecosystem work with NVIDIA (NVLink Fusion), AMD (UALink), and Alchip. The press release describes the results as preliminary and furnishes them under Item 2.02, so they are not deemed filed under Section 18 of the Exchange Act. Quality of earnings deserves attention. GAAP net income of $51.2 million exceeded GAAP operating income by roughly $11.4 million, driven by $10.9 million of interest income on the company's roughly $1.07 billion in cash and marketable securities and a small $0.6 million tax benefit. The non-GAAP tax rate for the quarter was about 9%, well below the roughly 20% non-GAAP rate guided for Q3, so the outlook implies a meaningful headwind to EPS growth from taxes. Inventory rose to $58.6 million from $43.2 million at year-end 2024, and prepaid and other assets also increased, which bears watching as the company scales volume shipments. For Q3 2025, management guided revenue of $203 million to $210 million (roughly 6% to 9% sequential growth), GAAP gross margin of about 75%, GAAP diluted EPS of $0.23 to $0.24, and non-GAAP diluted EPS of $0.38 to $0.39 on about 180 million shares. The guidance implies a sharp deceleration from Q2's 20% sequential growth, and the filing's forward-looking statements flag risks including customer concentration, quarterly revenue volatility, reliance on AI demand, geopolitical and tariff exposure, and the absence of long-term customer commitments.

Aug 5, 2025 8-K

Astera Labs 8-K Report, Shareholder Vote Results (Jun 10, 2025)

Astera Labs (ALAB) filed this 8-K under Item 5.07 to report the results of its 2025 Annual Stockholders Meeting, held June 5, 2025. Of the 164,914,754 shares entitled to vote, 144,451,882 (about 87.6%) were voted in person or by proxy. The filing contains no financial results, guidance, or operating metrics. Its substance is governance: stockholders re-elected three Class I directors and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2025. All three director nominees were elected, but support varied considerably. Jitendra Mohan and Bethany Mayer received strong majorities of votes cast, with withheld votes of roughly 2.3% and 7.5%, respectively. Stefan Dyckerhoff received about 72.7% For and 27.3% Withheld, a materially weaker level of support that investors may want to monitor. The filing does not state the reasons for the withheld votes. The auditor ratification passed with overwhelming support: 144,009,267 For (about 99.7% of votes cast), 253,622 Against, and 188,993 Abstain. For investors, the main takeaways are that governance proposals passed, the board's composition was retained, and the one notable signal is the elevated withhold vote for Mr. Dyckerhoff.

Jun 10, 2025 10-Q

Astera Labs Quarterly Report for Q1 Ended Mar 31, 2025

Astera Labs, Inc. (ALAB) has reported a strong first quarter for 2025, with a significant 144% year-over-year increase in revenue, reaching $159.4 million. This growth is primarily attributed to higher unit shipments of their Aries and Taurus product lines, coupled with an increased mix of hardware modules contributing to higher average selling prices. Despite the revenue surge, gross margin saw a slight decrease of 250 basis points to 74.9%, mainly due to the aforementioned product mix. The company has also demonstrated a considerable reduction in operating expenses, down 19% year-over-year. This was largely driven by a significant decrease in non-cash stock-based compensation expense following the IPO in the prior year. However, personnel-related expenses increased by 72% due to a substantial rise in headcount, alongside increased investments in research and development. Astera Labs has achieved profitability this quarter with a net income of $31.8 million, a stark contrast to the net loss reported in the same period last year.

May 7, 2025 8-K

Astera Labs 8-K Report, Financial Results (May 6, 2025)

Astera Labs (ALAB) reported first-quarter 2025 results on May 6, 2025 that showed strong top-line growth and solid profitability. Revenue reached a record $159.4 million, up 13% sequentially from $141.1 million and up 144% year-over-year from $65.3 million. GAAP gross margin was 74.9% and GAAP operating income was $11.3 million (7.1% margin), while GAAP net income was $31.8 million, or $0.18 per diluted share. On a non-GAAP basis, which excludes stock-based compensation, operating income was $53.7 million (33.7% margin) and diluted EPS was $0.33. The company attributed growth to demand for PCIe scale-up and Ethernet scale-out connectivity in custom ASIC platforms, early shipments of Scorpio P-Series and Aries 6 retimers for merchant GPU platforms, and a planned ramp of PCIe 6 products in leading GPU-based rack-scale systems beginning in Q2. For the second quarter of 2025, management guided to revenue of $170 million to $175 million, GAAP gross margin of approximately 74%, and non-GAAP diluted EPS of $0.32 to $0.33 on roughly 178 million diluted shares. GAAP diluted EPS guidance is $0.10 to $0.11. Balance sheet strength is notable: cash, cash equivalents and marketable securities totaled about $924.7 million at quarter-end, and stockholders' equity rose to $1.04 billion. Accounts receivable jumped to $69.8 million from $38.8 million, and operating cash flow was a modest $10.5 million, so investors should watch receivable collection and inventory build alongside the growth story. The filing is a furnished (not filed) Item 2.02 report under Form 8-K, so the results are not subject to Section 18 liability unless specifically incorporated by reference. Key forward-looking risks flagged in the release include customer concentration, cyclicality of the semiconductor industry, dependence on AI demand, tariffs and geopolitical developments (including US-China trade), and absence of long-term customer commitments. Note also that the GAAP net income benefited from a $10.1 million income tax benefit, and that non-GAAP results exclude $42.4 million of stock-based compensation.

May 6, 2025 8-K

Astera Labs 8-K Report, Executive Changes (Mar 3, 2025)

Astera Labs (ALAB) filed an 8-K on March 3, 2025 to disclose the appointment of Dr. Craig Barratt to its Board of Directors. The Board expanded its size from seven to eight members and appointed Dr. Barratt effective March 2, 2025. The Board has determined he is independent under Nasdaq and SEC rules. He was designated a Class II director and intends to stand for election at the 2026 Annual Meeting of Stockholders. He also replaces Manuel Alba on the Audit Committee. The filing is governance-focused and contains no financial results, guidance, or material operational updates. The appointment is a routine board refresh, and Dr. Barratt brings a long record in networking and semiconductor leadership, including his former roles as CEO of Barefoot Networks, President of Atheros, and SVP at Google, plus his current chair role at Intuitive Surgical. For investors, the key governance points are the expanded board, the added audit committee expertise, and the standard compensation package. That package consists of a $60,000 annual Board retainer, a $12,500 annual Audit Committee retainer (both prorated for 2025), and a one-time RSU award worth $330,000 vesting over three years. The disclosure has limited near-term financial impact. The one-time RSU grant and retainers are modest relative to the company's scale, and the filing contains no related-party transactions or family relationships requiring disclosure. Investors should view this as a neutral governance event, with the main signal being the addition of a seasoned semiconductor and networking executive to oversight of a company focused on AI and cloud connectivity.

Mar 3, 2025 10-K

Astera Labs Annual Report, Year Ended Dec 31, 2024

Astera Labs (ALAB) reported a transformative 2024 in its first full year as a public company after its March 2024 IPO. Revenue rose 242% to $396.3 million from $115.8 million, driven by a 217% increase in unit shipments, primarily of its Aries PCIe/CXL Smart DSP Retimers, and a richer product mix of hardware modules. Gross margin expanded 750 basis points to 76.4%, helped by lower inventory write-downs, and the company generated $136.7 million in operating cash flow. GAAP results remained loss-making, with a net loss of $83.4 million and an operating margin of -29.3%, largely because of $234.6 million in stock-based compensation, much of it tied to RSUs whose liquidity condition was satisfied by the IPO. On a non-GAAP basis, the company posted operating income of $119.6 million (30.2% margin) and net income of $143.3 million. The balance sheet is strong, with $914.3 million in cash, cash equivalents, and marketable securities after the IPO raised $672.2 million in net proceeds. Concentration is the central risk: the top three end customers accounted for approximately 80% of 2024 revenue, with Customer A alone at 36%, and TSMC is the sole source for integrated circuits. Taiwan (68% of revenue) and China (18%) are also significant exposures given trade restrictions. The company also disclosed material weaknesses in internal control over financial reporting, covering risk assessment, segregation of duties, and IT general controls, which remained unremediated at year-end, and its disclosure controls were concluded to be ineffective. Investors should weigh strong growth and margins against customer concentration, geopolitical exposure, control remediation, and heavy dilution from equity awards.

Feb 14, 2025 8-K

Astera Labs 8-K Report, Financial Results (Feb 10, 2025)

Astera Labs (ALAB) reported preliminary fourth-quarter and full-year 2024 results on February 10, 2025, with record revenue of $141.1 million in Q4 (up 25% sequentially and 179% year-over-year) and full-year revenue of $396.3 million (up 242%). Q4 GAAP gross margin was 74.0% and GAAP operating income was roughly break-even at $0.1 million, while non-GAAP operating income was $48.4 million (34.3% margin). Full-year GAAP results showed an operating loss of $116.1 million and a net loss of $83.4 million, driven largely by $234.6 million of stock-based compensation, including $88.9 million of one-time expense tied to the IPO's liquidity-event vesting condition. Full-year non-GAAP operating income was $119.6 million (30.2% margin). The balance sheet strengthened substantially following the IPO, with total assets rising to $1.05 billion from $196 million and marketable securities of $835 million. Operating cash flow turned positive at $136.7 million for 2024, versus an outflow of $12.7 million in 2023. Accounts receivable rose to $38.8 million from $8.3 million and inventory to $43.2 million from $24.1 million, which warrants monitoring alongside the revenue ramp. For Q1 2025, management guided revenue of $151 million to $155 million, GAAP gross margin of about 74%, and non-GAAP diluted EPS of $0.28 to $0.29. Management characterized 2025 as a "breakout year" driven by all four product families, including the Scorpio Fabric switches for head-node PCIe connectivity and backend AI accelerator scale-up. Revenue in 2024 was concentrated in the Aries PCIe retimer family, so investors will be watching diversification and customer concentration as the company scales.

Feb 10, 2025 8-K

Astera Labs 8-K Report, Material Agreement (Dec 20, 2024)

Astera Labs, Inc. has entered into a material definitive agreement, a lease for approximately 154,231 square feet of office space in San Jose, California. This lease signifies a strategic move for the company, as it plans to relocate its corporate headquarters to this new location upon the completion of construction and the expiration of its current lease, expected in the second quarter of 2025. The new headquarters will support the company's growth and operational needs.

Dec 20, 2024 10-Q

Astera Labs Quarterly Report for Q3 Ended Sep 30, 2024

Astera Labs, Inc. (ALAB) has reported significant revenue growth in its Q3 2024 10-Q filing, with revenues increasing by 206% year-over-year for the three months ended September 30, 2024, and by 291% for the nine months ended September 30, 2024. This growth is primarily attributed to increased demand for its Aries products and a favorable product mix, including higher-selling second-generation retimers. The company also achieved a substantial improvement in gross margin, reaching 77.7% for both the three and nine-month periods, up from 76.1% and 62.5% in the prior year periods, respectively. This improvement is due to product mix, lower unit costs, and reduced inventory write-downs. Despite the strong revenue and gross profit performance, the company continues to operate at a net loss, reporting a net loss of $7.6 million for the third quarter and $108.1 million for the first nine months of 2024. This is largely driven by substantial increases in operating expenses, particularly R&D and SG&A, which saw significant jumps due to non-cash stock-based compensation expenses related to its IPO, and increased personnel costs from higher headcount. The company's cash position remains robust, bolstered by its March 2024 IPO, with cash, cash equivalents, and marketable securities totaling $886.8 million as of September 30, 2024.

Nov 5, 2024 8-K

Astera Labs 8-K Report, Financial Results (Nov 4, 2024)

Astera Labs (ALAB) reported preliminary third-quarter fiscal 2024 results (quarter ended September 30, 2024) via an 8-K furnished on November 4, 2024. Revenue was a record $113.1 million, up 47% sequentially and 206% year-over-year, marking the company's fifth consecutive quarterly revenue record. GAAP gross margin was 77.7%, GAAP operating loss narrowed to $8.9 million (a -7.9% operating margin, versus -31.6% in the prior quarter), and GAAP net loss was $7.6 million, or $0.05 per share. On a non-GAAP basis, which excludes stock-based compensation, operating income was $36.6 million (32.4% margin) and non-GAAP diluted EPS was $0.23. Note that the GAAP quarterly figures include a $10.9 million interest income contribution and a $9.6 million income tax provision, so the GAAP pre-tax line was roughly breakeven. Management attributed the growth to multiple product families ramping across AI platforms based on both third-party GPUs and internally developed AI accelerators, and highlighted the new Scorpio Smart Fabric Switch family (P-Series for PCIe Gen 6 GPU-to-CPU/NIC/SSD connectivity and X-Series for back-end GPU clustering), which is shipping in pre-production quantities. The company also joined the UALink Consortium as a promoting member on its Board of Directors. For fourth-quarter fiscal 2024, management guided revenue of $126 million to $130 million, GAAP gross margin of approximately 75%, and non-GAAP diluted EPS of $0.25 to $0.26 on roughly 179 million shares. Investors should weigh the sharp rise in GAAP stock-based compensation (about $186 million for the first nine months, including $88.9 million of one-time IPO-related expense), the heavy reliance on a concentrated hyperscaler customer base, and the company's recent IPO-related cash position (about $886 million in cash and marketable securities at quarter end) against these strong growth figures. The filing's forward-looking statements also flag risks including customer concentration, AI demand volatility, and China-related trade and geopolitical exposure.

Nov 4, 2024 10-Q

Astera Labs Quarterly Report for Q2 Ended Jun 30, 2024

Astera Labs, Inc. reported significant revenue growth in the second quarter of 2024, with revenues reaching $76.9 million, a substantial increase of 619% compared to the same period last year. This growth was primarily driven by strong demand for its Aries products, coupled with an increased mix of higher-priced second-generation products. Despite this revenue surge, the company reported a net loss of $7.5 million for the quarter, although this is an improvement from the $20.0 million net loss in Q2 2023. The company's gross margin remained strong at 77.9% for the quarter. The significant increase in operating expenses, particularly research and development and sales and marketing, is largely attributable to a substantial rise in non-cash stock-based compensation expense following the company's Initial Public Offering (IPO) in March 2024. The company successfully completed its IPO, raising $672.2 million in net proceeds, which significantly bolstered its cash position to $831.0 million in cash, cash equivalents, and marketable securities as of June 30, 2024. Management believes this liquidity is sufficient for at least the next 12 months.

Aug 7, 2024 8-K

Astera Labs 8-K Report, Financial Results (Aug 6, 2024)

Astera Labs (ALAB) reported preliminary results for the second quarter of fiscal 2024 (ended June 30, 2024), delivering revenue of $76.9 million, up 18% sequentially and 619% year-over-year, with a GAAP gross margin of 77.9% and non-GAAP gross margin of 78.0%. GAAP operating loss narrowed to $24.3 million, largely because the prior quarter carried a large one-time stock-based compensation charge tied to the IPO. Non-GAAP operating income was $18.7 million and non-GAAP diluted EPS was $0.13. The company also guided Q3 revenue to $95-100 million, implying roughly 24-30% sequential growth, with a GAAP diluted loss per share of $0.06-$0.08 and non-GAAP diluted EPS of $0.16-$0.17. Management attributed the outlook to the production ramp of new AI platforms at hyperscalers using both third-party and internally developed accelerators. The balance sheet strengthened substantially after the IPO. Cash and cash equivalents rose to $421.1 million and marketable securities to $409.9 million, versus $45.1 million and $104.2 million at year-end 2023. Operating cash flow was positive $33.5 million for the first half of 2024. Stockholders' equity increased to $845.3 million, and the redeemable convertible preferred stock was fully converted to common equity. The filing also disclosed that lock-up restrictions on officers, directors, and substantially all major holders will expire at the open of trading on August 8, 2024, two trading days after the earnings release. This removes a significant overhang and may increase share supply, a factor investors should weigh. Investors should also note that the GAAP results include substantial stock-based compensation of $43.1 million in the quarter, and that the company's revenue remains concentrated among a limited number of hyperscale and AI platform customers.

Aug 6, 2024 8-K

Astera Labs 8-K Report, Executive Changes (Jun 24, 2024)

Astera Labs, Inc. (Nasdaq: ALAB) filed a Form 8-K on June 24, 2024 to report the appointment of Bethany Mayer to its Board of Directors. The Board, on June 23, 2024, increased its authorized size from six to seven seats and appointed Mayer as an independent Class I director, with a plan to stand for election at the 2025 Annual Meeting. She also joins the Audit Committee effective July 25, 2024, replacing Stefan Dyckerhoff on that committee. This is a governance event rather than a financial one, and the filing contains no financial results, guidance, or material transactions. Mayer brings substantial public-company and technology leadership experience, including former CEO of Ixia (sold to Keysight in 2017), former HP networking unit leader, and current board roles at Hewlett Packard Enterprise, LAM Research, Sempra Energy, and Box, Inc. (where she chairs). Her background in networking, test, and semiconductor markets aligns with Astera Labs' focus on PCIe, CXL, and Ethernet connectivity for AI and cloud infrastructure. Her compensation is consistent with the company's standard non-employee director program, plus a one-time RSU grant valued at $330,000 vesting over three years. For investors, the appointment adds an experienced director with audit committee service and relevant industry experience, which can be viewed as a modest positive for board oversight. The filing does not indicate any disagreement with management, related-party transactions, or change in the company's operating outlook. The announcement was made shortly after the company's IPO, and the 8-K is best read as routine board-refresh disclosure.

Jun 24, 2024 10-Q

Astera Labs Quarterly Report for Q1 Ended Mar 31, 2024

Astera Labs, Inc. (ALAB) reported strong revenue growth in the first quarter of 2024, with revenue increasing 269% year-over-year to $65.3 million, primarily driven by demand for its Aries product and a 20% increase in average selling prices. The company also saw a significant improvement in gross margin, expanding by 53.3 percentage points to 77.4%, attributed to higher selling prices and the absence of a prior year inventory write-down. Despite the impressive top-line growth and margin expansion, Astera Labs continues to operate at a net loss, reporting a net loss of $93.0 million for the quarter. This loss was significantly impacted by increased operating expenses, particularly a substantial rise in stock-based compensation expense related to the company's recent Initial Public Offering (IPO). The company completed its IPO on March 22, 2024, raising $672.2 million in net proceeds. While the company's cash position has strengthened considerably post-IPO, investors should monitor the path to profitability amidst ongoing investments in research and development and sales and marketing.

May 8, 2024 8-K

Astera Labs 8-K Report, Financial Results (May 7, 2024)

Astera Labs (ALAB) reported record first-quarter 2024 revenue of $65.3 million, up 29% sequentially and 269% year-over-year, driven by accelerating AI infrastructure deployments. GAAP gross margin was 77.4% and non-GAAP gross margin was 78.2%. The company posted a GAAP operating loss of $83.0 million and a GAAP net loss of $93.0 million, or $(1.77) per share. The GAAP loss is dominated by roughly $88.9 million of one-time stock-based compensation recognized when restricted stock units vested in connection with the March 2024 IPO. On a non-GAAP basis, the company generated operating income of $15.9 million, net income of $14.3 million, and pro forma diluted EPS of $0.10. Operating cash flow was modestly positive at $3.7 million. The balance sheet was substantially strengthened by the IPO of 22.77 million shares at $36.00, which netted $672.2 million. Cash and cash equivalents rose to $696.1 million from $45.1 million at year-end 2023, and total stockholders' equity reached $808.8 million, up from a deficit of $(97.7) million. Working capital build was visible, with accounts receivable roughly doubling to $16.8 million and inventory rising to $29.6 million, consistent with the sequential growth in shipments. For Q2 2024, management guided revenue up 10% to 12% sequentially, implying roughly $71.8 million to $73.1 million. Guidance calls for non-GAAP gross margin of about 77% and non-GAAP operating expenses of about $40 million, with non-GAAP diluted EPS of about $0.11 on approximately 180 million diluted shares. GAAP operating expenses are expected to be about $79 million, including roughly $39 million of stock-based compensation. Investors should note that these results are described as preliminary, and that the full Form 10-Q, with complete risk disclosures, had yet to be filed.

May 7, 2024 8-K

Astera Labs 8-K Report, Corporate Update (May 3, 2024)

Astera Labs, Inc. (ALAB) has filed an 8-K to provide an update on its post-Initial Public Offering (IPO) lock-up agreements. A significant portion of shares held by certain employees, referred to as "Early Release Shares," will become eligible for sale on May 9, 2024. This early release is contingent upon the satisfaction of a specific stock price performance condition, which has been met. The company will announce its first-quarter 2024 financial results on May 7, 2024, after market close. While this early unlock for a portion of employee shares is a key development, it's crucial for investors to note that lock-up restrictions remain in place for all other shares held by officers, directors, and other significant stockholders until the original lock-up period expires. This original period ends on the earlier of 180 days from March 19, 2024, or the second trading day following the company's earnings release for the quarter ending June 30, 2024. Investors should monitor potential selling pressure from the ~20% of eligible employee shares becoming available.

May 3, 2024 8-K

Astera Labs 8-K Report, Unregistered Securities Sale (Mar 28, 2024)

This 8-K filing from Astera Labs, Inc. (ALAB) primarily details the completion of its Initial Public Offering (IPO) on March 22, 2024. The company successfully offered 22,770,000 shares of Common Stock at an initial price of $36.00 per share. Of these, 19,758,903 shares were sold by Astera Labs itself, including the full exercise of the underwriters' option for an additional 2,970,000 shares. Certain selling stockholders also sold 3,011,097 shares, with the company not receiving proceeds from those sales. Furthermore, the filing confirms the automatic conversion of all outstanding preferred stock into 90,890,650 shares of common stock, which occurred immediately prior to the IPO's closing. This conversion was conducted on a one-for-one basis and was not registered under the Securities Act of 1933, relying on an exemption for unregistered sales of equity securities. The company also updated its corporate governance documents, filing an amended and restated certificate of incorporation and bylaws, effective upon the IPO's consummation.

Mar 28, 2024